Sheffield Hallam University
Also known as: Academic Unit of Clinical Oncology, University of Sheffield | Amrit Sinha | Children's Hospital - Sheffield | EORTC Trial Co-Chair, University of Sheffield, Sheffield, UK | Human Nutrition Unit, University of Sheffield | Investigator | Royal Hallamshire Hospital | Royal Hallamshire Hospital, Sheffield, England | Sheffield Children's Hospital | Sheffield Children's Hospital, The Academic Unit of Child Health | Sheffield Children's NHS Foundation Trust | Sheffield Hallam University | Sheffield NHS Trust | Sheffield Teaching Hopsitals Trust | Sheffield Teaching Hosiptals NHS Foundation Trust | Sheffield Teaching Hospital | Sheffield Teaching Hospitals | Sheffield Teaching Hospitals NHS Foundation Trust | Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital | Sheffield Teaching Hospitals NHS Foundation Trust/University of Sheffield | Sheffield Teaching Hospitals NHS Foundation Trust, Weston Park Hospital, Sheffield, S10 2SJ, UK | Sheffield Teaching Hospitals NHS FT | Sheffield Teaching Hospitals NHS Trust | Sheffield University | The University of Sheffield & Sheffield Teaching Hospitals NHS FT | University of Sheffield | University of Sheffield, Metabolic Bone Centre, Northern General Hospital, Sheffield S5 7AU, United Kingdom | University of Sheffield School of Clinical Dentistry | University of Sheffield / Sheffield Teaching Hospitals NHS Foundation Trust | Urology Department, Royal Hallamshire Hospital, University of Sheffield, Glossop Road, Sheffield, S10 2JF, UK | Weston Park Hospital, Sheffield, UK
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1992Last known activity
Dec 30, 2024
Timeline
1840s
- Jan 1, 1843
Sheffield Hallam University— Founded
Drugs by trial phase (151 distinct, 113 trials)
Phase 4 (40 own, 0 via acquisition)
Phase 3 (34 own, 0 via acquisition)
Phase 2 (41 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Amyotrophic Lateral Sclerosis
- Angina Pectoris
- Angina, Stable
- Breast Neoplasms
- Cancer Pain
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Celiac Disease
- Communicable Diseases
- Constipation
- Coronary Artery Disease
- Cystic Fibrosis
- Delirium
- Dermatitis
- Dermatitis, Atopic
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Diarrhea
- Eczema
- Endometriosis
- Epilepsy
- Exocrine Pancreatic Insufficiency
- Eye Diseases
- Familial Primary Pulmonary Hypertension
- Fatty Liver
- Fibrosis
- Foot Deformities
- Foot Deformities, Congenital
- Graves Ophthalmopathy
- Hemangiosarcoma
- Hematologic Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- HIV Infections
- Hyperplasia
- Hypertension
- Hypogonadism
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Inflammatory Bowel Diseases
- Irritable Bowel Syndrome
- Leg Length Inequality
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Juvenile
- Lung Diseases
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Mesothelioma
- Motor Neuron Disease
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Myelodysplastic Syndromes
- Myocardial Infarction
- Nelson Syndrome
- Neoplasm Metastasis
- Neuroblastoma
- Non-alcoholic Fatty Liver Disease
- Osteogenesis Imperfecta
- Osteoporosis
- Osteoporosis, Postmenopausal
- Pain
- Parkinson Disease
- Pelvic Pain
- Peripheral Nervous System Diseases
- Plaque, Atherosclerotic
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Hyperplasia
- Recurrence
- Renal Insufficiency
- Sarcoma
- Sarcoma, Kaposi
- Sclerosis
- Shock
- Shock, Septic
- Signs and Symptoms
- Syndrome
- Thyroid Diseases
- Tinnitus
- Urinary Bladder, Overactive
- Uterine Cervical Neoplasms
- Uveitis
Recent trials (50)
- NCT05154851Overall official - principal investigatorN/A—
- NCT06740201OfficialPhase 4Dec 30, 2024
- NCT06508424OfficialN/AJul 31, 2024
- NCT06508424Lead sponsorN/AJul 31, 2024
- NCT06508424Sponsor investigatorN/AJul 31, 2024
- NCT06255951OfficialPhase 1Mar 4, 2024
- NCT05806814Overall official - principal investigatorPhase 1Nov 12, 2023
- NCT06003049Overall official - principal investigatorPhase 2Sep 1, 2023
- NCT05825417Overall official - principal investigatorPhase 4Jun 14, 2023
- NCT05825417Lead sponsorPhase 4Jun 14, 2023
- NCT05825417CollaboratorPhase 4Jun 14, 2023
- NCT05857514Overall official - principal investigatorN/AMay 10, 2023
- NCT05857514OfficialN/AMay 10, 2023
- NCT05671562Lead sponsorN/AMay 3, 2023
- NCT05671562CollaboratorN/AMay 3, 2023
Details
- Founded
- Sheffield, GB Jan 1, 1843
- Last known activity
- Dec 30, 2024